Impact of Metastatic Colorectal Cancer Stage and Number of Treatment Courses on Patient Health Care Costs and Utilization

References

• . Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J C/m.2013;63(1):11–30
   PubMed Web of Science ®Google Scholar
• . Soreide K, Berg M, Skudal BS, Nedreboe BS. Advances in the understanding and treatment of colorectal cancer. Discov Med. 2011;12(66):393–404
   PubMedGoogle Scholar
• . Fingerote RJ, Plantz SH, Talavera F, Balentine JR. Colon cancer. eMedicine-Health website, http://www.emedicinehealth.com/colon_cancer/article_em.htm. Accessed September 14, 2012
   Google Scholar
• . Marin JJ, Sanchez de Medina F, Castano B, . Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer. Drug Metab Rev. 2012;44(2):148–172
   PubMed Web of Science ®Google Scholar
• . Bartlett DL, Chu E. Can metastatic colorectal cancer be cured? Oncology (Williston Park). 2012;26(3):266–275
   PubMedGoogle Scholar
• . Engstrom PF; National Comprehensive Cancer Network. Systematic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy. Pharmacotherapy. 2008;28(11 pt 2):18S–22S
   Google Scholar
• . Natarajan N, Sinister TD. New agents, combinations, and opportunities in the treatment of advanced and early-stage colon cancer. Surg Clin North Am. 2006;86(4):1023–1043
   PubMedGoogle Scholar
• . Di Cristofaro L, Scarpa M, Angriman I, . Cost-effectiveness analysis of postoperative surveillance protocols following radical surgery for colorectal cancer. Acta Chir Belg. 2012;112(1):24–32
   PubMed Web of Science ®Google Scholar
• . National Cancer Institute. Colon cancer treatment (PDQ). http://cancer.gov/cancertopics/pdq/treatment/colon/HealthProfessional/. Updated February 8, 2013. Accessed September 14, 2012
   Google Scholar
• . National Cancer Institute. Rectal cancer treatment (PDQ). http://cancer.gov/cancertopics/pdq/treatment/rectal/HealthProfessional/. Updated February 8, 2013. Accessed September 14, 2012
   Google Scholar
• . Chua TC, Liauw W, Chu F, Morris DL. Viewing metastatic colorectal cancer as a curable chronic disease. Am J Clin Oncol. 2012;35(1):77–80
   PubMed Web of Science ®Google Scholar
• . Paramore LC, Thomas SK, Knopf KB, Cragin LS, Fraeman KH. Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer. Clin Colorectal Cancer. 2006;6(1):52–58
   PubMed Web of Science ®Google Scholar
• . Penberthy L, Retchin SM, McDonald MK, . Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer. Health Care Manag Sci. 1999;2(3):149–160
   PubMedGoogle Scholar
• . Mittmann N, Au HJ, Tu D, O'Callaghan CJ, ; Working Group on Economic Analysis of National Cancer Institute of Canada Clinical Trials Group; Australasian Gastrointestinal Interest Group. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial. J Natl Cancer Inst. 2009;101(17):1182–1192
   PubMedGoogle Scholar
• . Ferro SA, Myer BS, Wolff DA, . Variation in the cost of medications for the treatment of colorectal cancer. Am J Manag Care. 2008;14(11):717–725
   PubMedGoogle Scholar
• . Caponero R, Ribeiro Rde A, Santos E, Cirrincione A, Saggia M. Medical resource use and cost of different first-line treatments for metastatic colorectal cancer in Brazil. J Med Econ. 2008;11(2):311–325
   PubMedGoogle Scholar
• . Cassidy J, Douillard JY, Twelves C, . Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial. Br J Cancer. 2006;94(8):1122–1129
   PubMedGoogle Scholar
• . Song X, Long SR, Barber B, . Systematic review on infusion reactions associated with chemotherapies and monoclonal antibodies for metastatic colorectal cancer. Curr Clin Pharmacol. 2012;7(1):56–65
   PubMedGoogle Scholar
• . Burudpakdee C, Zhao Z, Munakata J, Gao S, Trochlil K, Barber B. Economic burden of toxicities associated with metastatic colorectal cancer treatment regimens containing monoclonal antibodies. J Med Econ. 2012;15(2):371–377
   PubMedGoogle Scholar
• . Dranitsaris G, Maroun J, Shah A. Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea. Can J Gastroenterol. 2005;19(2):83–87
   PubMed Web of Science ®Google Scholar
• . Wong YN, Meropol NJ, Speier W, Sargent D, Goldberg RM, Beck JR. Cost implications of new treatments for advanced colorectal cancer. Cancer. 2009;115(10):2081–2091
   PubMed Web of Science ®Google Scholar
• . Corral MJ, Clopès A, Navarro M, Germà JR, Borràs JM. Impact on budget of new drugs for colorectal cancer treatment [in Spanish]. Med Clin (Bare). 2007;129(4):134–136
   PubMed Web of Science ®Google Scholar
• . Delcò F, Egger R, Bauerfeind P, Beglinger C. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland. Aliment Pharmacol Ther. 2005;21(5):615–622
   PubMedGoogle Scholar
• . Health Insurance Portability and Accountability Act of 1996. Public law 104–191, 104th Congress, US Department of Health and Human Services. 1996. http://www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdf. Accessed June 12, 2012
   Google Scholar
• . Social Security Administration. Death Master File. http://www.ssdmf.com/FolderID/l/SessionID/%7B2DE0F1B2-6D7A-43EE-B764-DCC7804C8CD2%7D/PageVars/Library/InfoManage/Guide.htm. Updated weekly. Accessed June 12, 2012
   Google Scholar
• . Edge SB, Byrd DR, Compton CC, , eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010
   Google Scholar
• . Hess GP, Wang PF, Quach D, Barber B, Zhao Z. Systemic therapy for metastatic colorectal cancer: patterns of chemotherapy and biologic therapy use in US medical oncology practice. J Oncol Pract. 2010;6(6):301–307
   PubMedGoogle Scholar
• . Song X, Zhao Z, Barber B, Gregory C, Wang PF, Long SR. Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics. Curr Med Res Opin. 2011;27(1):123–130
   PubMed Web of Science ®Google Scholar
• . US Department of Labor, Bureau of Labor Statistics. Consumer Price Index. Chained Consumer Price Index for All Urban Consumers (C-CPI-U) 1999–2008, Medical Care. Series ID: SUUR0000SAM. Washington, DC: US Dept of Labor, Bureau of Labor Statistics, 2008. http://data.bls.gov/cgi-bin/surveymost7su. Accessed June 12, 2012
   Google Scholar
• . Blough DK, Ramsey SD. Using generalized linear models to assess medical care costs. Health Serv Outcomes Res Methodol. 2000;1: 185–202
   Google Scholar
• . Ramsey SD, Berry K, Etzioni R. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer. Am J Gastroenterol. 2002;97(2):440–445
   PubMedGoogle Scholar
• . Bradley CJ, Lansdorp-Vogelaar I, Yabroff KR, . Productivity savings from colorectal cancer prevention and control strategies. Am J Prev Med. 2011;41(2):e5–e14
   PubMed Web of Science ®Google Scholar
• . Jessup J, McGinnis L, Steele GD Jr, Menck HR, Winhester DP. The National Cancer Database Report on Colon Cancer. Cancer 1996;78(4):918–926
   PubMedGoogle Scholar
• . Schrag D, Cramer L, Bach P, . Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93(11):850–857
   PubMed Web of Science ®Google Scholar
• . Dotan E, Browner I, Hurria A, Denlinger C. Challenges in the management of older patients with colon cancer. J Natl Compr Canc Netw. 2012;10(2):213–224
   PubMed Web of Science ®Google Scholar
• . Crea F, Nobili S, Paolicchi E, . Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and therapeutic strategies. Drug Resist Updat. 2011;14(6):280–296
   PubMed Web of Science ®Google Scholar